2025年5月23日 周五
Home > Archive>Volume 29, Issue 5, 2021 >451-455
PDF HTML XML Export Cite reminder
Research status of biomarkers for acute coronary syndrome
Author:
Affiliation:

1.Department of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan 637000;2.Department of Cardiology, the First Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference
    • |
  • Related
    • |
  • Cited by
    • | |
  • Comments
    Abstract:

    With the incidence rate of coronary heart disease increasing year by year, the research on biomarkers of acute coronary syndrome has been deepened. At present, the clinical biomarkers commonly used in the diagnosis of acute coronary syndrome are myoglobin, creatine kinase isoenzyme, troponin, hypersensitive troponin and so on. More and more biomarkers have been found to be useful for early diagnosis, risk stratification and prognosis evaluation of acute coronary syndrome. According to the mechanism and physiological effect of cardiac biomarkers, they can be divided into myocardial cell injury biomarkers, endothelial cell related biomarkers, biomarkers of biological mechanical strain, inflammatory factor related biomarkers and so on. This paper reviews the research progress in this field in recent years.

    Reference
    Related
    Cited by
Get Citation

TANG Kai, SHUAI Zhuang, LI Zongyu, ZHOU Luwei, GOU Jungqi, WANG Yuquan, LYU Zhan. Research status of biomarkers for acute coronary syndrome[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2021,29(5):451-455.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 04,2020
  • Revised:December 28,2020
  • Online: April 23,2021
Article QR Code

You are the visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025